ホーム › 骨髄異形成症候群 › コロンビア特別区 › Washington
Washington、DCにおける骨髄異形成症候群の臨床試験
Washingtonとその周辺地域（約30マイル以内）の拠点で、骨髄異形成症候群に関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
被験者募集中第1/2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
被験者募集中第1/2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
CHIP/CCUS Natural History Protocol
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Natural History Study of GATA2 Deficiency and Related Disorders
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
被験者募集中第2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Collection of Tissue Samples for Cancer Research
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- Children's National Medical Center, Washington D.C.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
被験者募集中第2相
- The Center for Cancer and Blood Disorders (CCBD) - Bethesda, Bethesda · 7マイル先
Mosaic Trial for Stem Cell Transplant Recipients
被験者募集中
- Georgetown University School of Medicine, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
被験者募集中第2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
被験者募集中観察研究健康なボランティア歓迎
- Cancer Support Community Research & Training Institute, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
被験者募集中第1/2相
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Silver Spring · 7マイル先
- Massive Bio SYNERGY-AI site, Bethesda · 7マイル先
他の都市における骨髄異形成症候群の試験
- Houston, TX43件の研究
- Baldwin Park, CA26件の研究
- New York City, NY21件の研究
- Seattle, WA21件の研究
- Tampa, FL19件の研究
- Boston, MA19件の研究
- Miami, FL17件の研究
- Columbus, OH14件の研究
- Durham, NC14件の研究
- St. Louis, MO13件の研究
- Atlanta, GA13件の研究
- Chicago, IL13件の研究
Washingtonにおける他の研究
- がん（全種類）58件の研究
- 非小細胞肺癌55件の研究
- 乳がん46件の研究
- 転移性癌43件の研究
- 肺がん41件の研究
- 前立腺がん38件の研究
- 肥満症33件の研究
- 大腸癌29件の研究
- 心血管疾患28件の研究
- 膀胱癌26件の研究
- 急性骨髄性白血病24件の研究
- 卵巣がん23件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。